FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

732981002: Actuation (unit of presentation)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2017. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3498507019 Actuation (unit of presentation) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3498508012 Actuation en Synonym Active Entire term case insensitive SNOMED CT core module
105633401000001114 actuation en Synonym Active Entire term case sensitive SNOMED CT United Kingdom Edition module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Actuation Is a Unit of presentation true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely prednisolone (as prednisolone metasulfobenzoate sodium) 20 milligram/1 actuation conventional release rectal foam (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely budesonide 80 microgram and formoterol fumarate dihydrate 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely budesonide 80 microgram and formoterol fumarate dihydrate 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 2
Product containing precisely budesonide 80 microgram and formoterol fumarate dihydrate 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely budesonide 160 microgram and formoterol fumarate dihydrate 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely budesonide 160 microgram and formoterol fumarate dihydrate 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 2
Product containing precisely budesonide 160 microgram and formoterol fumarate dihydrate 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely ambroxol hydrochloride 2.5 milligram/1 actuation conventional release oromucosal spray (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely ambroxol hydrochloride 2.5 milligram/1 actuation conventional release oromucosal spray (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely formoterol fumarate dihydrate 12 microgram and tiotropium (as tiotropium bromide) 18 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely formoterol fumarate dihydrate 12 microgram and tiotropium (as tiotropium bromide) 18 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely formoterol fumarate dihydrate 12 microgram and tiotropium (as tiotropium bromide) 18 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 2
Product containing precisely flurbiprofen 2.91 milligram/1 actuation conventional release oromucosal spray (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely flurbiprofen 2.91 milligram/1 actuation conventional release oromucosal spray (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely nicotine 1 milligram/1 actuation conventional release oromucosal spray (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely nicotine 1 milligram/1 actuation conventional release oromucosal spray (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely azelastine hydrochloride 140 microgram and fluticasone propionate 50 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely azelastine hydrochloride 140 microgram and fluticasone propionate 50 microgram/1 actuation conventional release nasal spray (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely azelastine hydrochloride 140 microgram and fluticasone propionate 50 microgram/1 actuation conventional release nasal spray (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 2
Product containing precisely ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation conventional release pressurized solution for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation conventional release pressurized solution for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation conventional release pressurized solution for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 2
Product containing precisely tiotropium (as tiotropium bromide) 2.5 microgram/1 actuation conventional release solution for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely tiotropium (as tiotropium bromide) 1.25 microgram/1 actuation conventional release solution for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely tiotropium (as tiotropium bromide) 1.25 microgram/1 actuation conventional release solution for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely ciclesonide 400 microgram and formoterol fumarate dihydrate 12 microgram and tiotropium (as tiotropium bromide) 18 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely ciclesonide 400 microgram and formoterol fumarate dihydrate 12 microgram and tiotropium (as tiotropium bromide) 18 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely ciclesonide 400 microgram and formoterol fumarate dihydrate 12 microgram and tiotropium (as tiotropium bromide) 18 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 2
Product containing precisely ciclesonide 400 microgram and formoterol fumarate dihydrate 12 microgram and tiotropium (as tiotropium bromide) 18 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 3
Product containing precisely fluticasone propionate 500 microgram and formoterol fumarate dihydrate 12 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely fluticasone propionate 500 microgram and formoterol fumarate dihydrate 12 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely fluticasone propionate 500 microgram and formoterol fumarate dihydrate 12 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 2
Product containing precisely ipratropium bromide 40 microgram and levosalbutamol (as levosalbutamol sulfate) 100 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely ipratropium bromide 40 microgram and levosalbutamol (as levosalbutamol sulfate) 100 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely ipratropium bromide 40 microgram and levosalbutamol (as levosalbutamol sulfate) 100 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 2
Product containing precisely budesonide 400 microgram and formoterol fumarate dihydrate 6 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely budesonide 400 microgram and formoterol fumarate dihydrate 6 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely budesonide 400 microgram and formoterol fumarate dihydrate 6 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 2
Product containing precisely beclometasone dipropionate 100 microgram and levosalbutamol (as levosalbutamol sulfate) 100 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely beclometasone dipropionate 100 microgram and levosalbutamol (as levosalbutamol sulfate) 100 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely beclometasone dipropionate 100 microgram and levosalbutamol (as levosalbutamol sulfate) 100 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 2
Product containing precisely fluticasone propionate 125 microgram and formoterol fumarate dihydrate 6 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely fluticasone propionate 125 microgram and formoterol fumarate dihydrate 6 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely fluticasone propionate 125 microgram and formoterol fumarate dihydrate 6 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 2
Product containing precisely tiotropium (as tiotropium bromide) 2.5 microgram/1 actuation conventional release solution for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely salbutamol (as salbutamol sulfate) 200 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely salbutamol (as salbutamol sulfate) 200 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely beclometasone dipropionate 50 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation pressurized conventional release solution for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely beclometasone dipropionate 50 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation pressurized conventional release solution for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely beclometasone dipropionate 50 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation pressurized conventional release solution for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 2
Product containing precisely levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation conventional release pressurized solution for inhalation (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation conventional release pressurized solution for inhalation (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely naloxone (as naloxone hydrochloride) 1.8 milligram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely naloxone (as naloxone hydrochloride) 1.8 milligram/1 actuation conventional release nasal spray (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely xylometazoline hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation True Actuation Inferred relationship Existential restriction modifier
Product containing precisely xylometazoline hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) Has presentation strength denominator unit True Actuation Inferred relationship Existential restriction modifier 1
Product containing precisely buserelin (as buserelin acetate) 100 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely fluticasone furoate 27.5 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely desmopressin acetate 10 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely isosorbide dinitrate 1.25 milligram/1 actuation conventional release sublingual spray (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely dexamethasone isonicotinate 20 microgram and tramazoline hydrochloride 120 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely flunisolide 25 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely beclometasone dipropionate 100 microgram/1 actuation conventional release pressurized solution for inhalation (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely nedocromil sodium 2 milligram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely estradiol hemihydrate 150 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely nicotine 500 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely estradiol hemihydrate 150 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely beclometasone dipropionate 100 microgram/1 actuation conventional release pressurized solution for inhalation (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely desmopressin acetate 10 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely nicotine 500 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely dexamethasone isonicotinate 20 microgram and tramazoline hydrochloride 120 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely buserelin (as buserelin acetate) 100 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely nedocromil sodium 2 milligram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely fluticasone furoate 27.5 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely flunisolide 25 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely isosorbide dinitrate 1.25 milligram/1 actuation conventional release sublingual spray (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely dexamethasone isonicotinate 20 microgram and tramazoline hydrochloride 120 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely flunisolide 25 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely isosorbide dinitrate 1.25 milligram/1 actuation conventional release sublingual spray (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely desmopressin acetate 10 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely nicotine 500 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely estradiol hemihydrate 150 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely nedocromil sodium 2 milligram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely fluticasone furoate 27.5 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely buserelin (as buserelin acetate) 100 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely nafarelin (as nafarelin acetate) 200 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely beclometasone dipropionate 100 microgram/1 actuation conventional release pressurized solution for inhalation (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier
Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) Has unit of presentation False Actuation Inferred relationship Existential restriction modifier

Start Previous Page 3 of 3

This concept is not in any reference sets

Back to Start